Trademark: 77395489
Word
YUNGSHIN
Status
Registered
Status Code
800
Status Date
Saturday, January 30, 2021
Serial Number
77395489
Registration Number
3914672
Registration Date
Tuesday, February 1, 2011
Mark Type
3000
Filing Date
Wednesday, February 13, 2008
Published for Opposition
Tuesday, March 24, 2009

Trademark Owner History
YUNG SHIN PHARM. IND. CO., LTD. - Original Registrant

Classifications
5 Gastro-intestinal treatment preparations; cough drops; calcium supplement; analgesic preparations; oral analgesics; anti-inflammatories; anesthetics for surgical and non-surgical uses; sedatives; respiratory stimulants; pharmaceutical preparations to enhance digestion; antacids; nausea treatment preparation; diarrhea medications; laxatives; diuretic preparations; antibiotics; hemostatics; appetite suppressants for medical use; diet pills; medicated hair restoration lotions; hair growth stimulants; medicated scalp treatment cream; smoking cessation preparations; eczema treatment preparations; hemorrhoid treatment preparations; psoriasis treatment preparations; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of arthritis; cough treatment preparations; highly caffeinated energy pills; breath-freshening chewing gum for medicinal purposes; blood plasma; antianginal preparation; acne treatment preparations; antipyretic analgesic; muscle relaxants; pharmaceutical anti-allergic preparations and substances; antidepressants; pharmaceutical preparations for the treatment of epilepsy, pharmaceutical preparations for the treatment of stomach ulcers, pharmaceutical preparations for the treatment of tuberculosis, pharmaceutical preparations for the treatment of Parkinson's disease, pharmaceutical preparations for the treatment of rheumatism, pharmaceutical preparations for the treatment of thrombosis, pharmaceutical preparations for the treatment of enuresis, pharmaceutical preparations for the treatment of hypertension, pharmaceutical preparations for the treatment of dermatosis; steroid ointments; human hormone for human use; pharmaceutical preparations for the prevention and treatment of disorders of the immune system; antihistamines; bronchodilators; pharmaceutical preparations for skin care; syringes sold filled with hyaluronic acid for use in arthroscopic surgeries; pharmaceutical preparations for the treatment of eye diseases and conditions; anti-cancer preparations; pharmaceutical preparations for treating diabetes; cholesterol reducers; hypnotics; preparations for treating colds; antiarrhythmics; oxytocics; expectorants; uterine contraction pharmaceutical preparations; contraceptives; athletes foot preparations; patches containing mosquito-repellent incenses for human use; vitamins; Chinese medicines, namely, herb teas for medicinal purposes, pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceuticals, namely, inducers of erections; hepatotonic agents for hepatological diseases; pharmaceutical preparations for the treatment of liver diseases; vaccines for human purposes; antivirals; ointments for pharmaceutical purposes, namely, non-steroid anti-inflammatory ointments; ocular pharmaceuticals, namely, eye-wash; patches containing anti-inflammatories; pharmaceutical preparations for hemopoiesis; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; pharmaceutical preparations for burn treatment; gelatin capsules sold empty for pharmaceuticals; suppositories; insect-repellents; pregnancy test kits for home use; diagnostic test kits consisting of diagnostic preparations for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; ovulation test kits; mineral nutritional supplements; dietary supplements in capsules containing garlic extract; medicinal ganoderma lucidum extracts for medical purposes; food supplements, namely, anti-oxidants; dietary supplements containing shark cartilage; vitamin and mineral supplements; dietary supplements in capsule forms containing shark liver oils; dietary supplements in capsule forms containing chitin extract; bread that is gluten-free to accommodate special medical and health conditions; dietary and nutritionally fortified food products adapted for medical use; dietary fiber powder as an additive for food products for restricted diet; dandruff shampoo
Color is not claimed as a feature of the mark.
The English translation of "YUNG SHIN" is "TRUST FOREVER".

Trademark Events
Dec 23, 2022
Teas Change Of Correspondence Received
Dec 23, 2022
Teas Change Of Domestic Representatives Address
Dec 23, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 23, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 30, 2021
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Jan 30, 2021
Registered And Renewed (First Renewal - 10 Yrs)
Jan 30, 2021
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jan 30, 2021
Case Assigned To Post Registration Paralegal
Nov 6, 2020
Teas Section 8 & 9 Received
Feb 1, 2020
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Dec 6, 2016
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Dec 6, 2016
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Dec 6, 2016
Case Assigned To Post Registration Paralegal
Sep 26, 2016
Teas Section 8 & 15 Received
Feb 1, 2011
Registered-Principal Register
Dec 28, 2010
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 27, 2010
Law Office Registration Review Completed
Dec 21, 2010
Allowed Principal Register - Sou Accepted
Dec 13, 2010
Statement Of Use Processing Complete
Dec 10, 2010
Use Amendment Filed
Dec 10, 2010
Teas Statement Of Use Received
Jul 13, 2010
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2010
Sou Extension 2 Granted
Jun 14, 2010
Sou Extension 2 Filed
Jul 12, 2010
Case Assigned To Intent To Use Paralegal
Jun 14, 2010
Teas Extension Received
Dec 7, 2009
Sou Extension 1 Granted
Dec 7, 2009
Sou Extension 1 Filed
Dec 7, 2009
Teas Extension Received
Jun 16, 2009
Noa Mailed - Sou Required From Applicant
Mar 24, 2009
Published For Opposition
Mar 4, 2009
Notice Of Publication
Feb 14, 2009
Law Office Publication Review Completed
Feb 14, 2009
Approved For Pub - Principal Register
Jan 2, 2009
Examiner's Amendment Entered
Jan 2, 2009
Notification Of Examiners Amendment E-Mailed
Jan 2, 2009
Examiners Amendment E-Mailed
Jan 2, 2009
Examiners Amendment -Written
Dec 12, 2008
Amendment From Applicant Entered
Dec 12, 2008
Correspondence Received In Law Office
Dec 12, 2008
Assigned To Lie
Dec 1, 2008
Paper Received
May 30, 2008
Notification Of Non-Final Action E-Mailed
May 30, 2008
Non-Final Action E-Mailed
May 30, 2008
Non-Final Action Written
May 27, 2008
Assigned To Examiner
Feb 20, 2008
Notice Of Design Search Code Mailed
Feb 19, 2008
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24